Cost-effectiveness of a Risk-Tailored Pancreatic Cancer Early Detection Strategy among Patients with New-Onset Diabetes

Screening for pancreatic ductal adenocarcinoma (PDAC) in asymptomatic adults is not recommended, but patients with new-onset diabetes (NoD) have an eight times higher risk of PDAC than expected. A novel risk-tailored early detection strategy targeting high-risk NoD patients might improve PDAC prognosis. We sought to evaluate the cost-effectiveness of this strategy.

Source: Clinical Gastroenterology and Hepatology - November 1, 2021 Category: Gastroenterology Authors: Louise Wang, Frank I. Scott, Ben Boursi, Kim A. Reiss, Sankey Williams, Henry Glick, Yu-Xiao Yang Source Type: research